Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Acute pulmonary embolism unmasking underlying chronic thromboembolic pulmonary hypertension and iliac vein compression syndrome.

Brener MI, Green P, Parikh SA, Sethi SS.

Catheter Cardiovasc Interv. 2019 Oct 8. doi: 10.1002/ccd.28525. [Epub ahead of print]

PMID:
31595624
2.

A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia.

Cohen JA, Rossi FM, Zucchetto A, Bomben R, Terzi-di-Bergamo L, Rabe KG, Degan M, Steffan A, Polesel J, Santinelli E, Innocenti I, Cutrona G, D' Arena G, Pozzato G, Zaja F, Chiarenza A, Rossi D, Di Raimondo F, Laurenti L, Gentile M, Morabito F, Neri A, Ferrarini M, Fegan CD, Pepper CJ, Del Poeta G, Parikh SA, Kay NE, Gattei V.

Haematologica. 2019 Oct 3. pii: haematol.2019.228171. doi: 10.3324/haematol.2019.228171. [Epub ahead of print]

3.

Mortality Assessment of Paclitaxel-Coated Balloons: Patient-Level Meta-Analysis of the ILLUMENATE Clinical Program at 3 Years.

Gray WA, Jaff MR, Parikh SA, Ansel GM, Brodmann M, Krishnan P, Razavi MK, Vermassen F, Zeller T, White R, Ouriel K, Adelman MA, Lyden SP.

Circulation. 2019 Oct;140(14):1145-1155. doi: 10.1161/CIRCULATIONAHA.119.040518. Epub 2019 Sep 30.

PMID:
31567024
4.

Total IN.PACT drug-coated balloon initiative reporting pooled imaging and propensity-matched cohorts.

Shishehbor MH, Schneider PA, Zeller T, Razavi MK, Laird JR, Wang H, Tieché C, Parikh SA, Iida O, Jaff MR.

J Vasc Surg. 2019 Oct;70(4):1177-1191.e9. doi: 10.1016/j.jvs.2019.02.030.

5.

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.

Abeykoon JP, Zanwar S, Ansell SM, Gertz MA, Kumar S, Manske M, Novak AJ, King R, Greipp P, Go R, Inwards D, Muchtar E, Habermann T, Witzig TE, Thompson CA, Dingli D, Lacy MQ, Leung N, Dispenzieri A, Gonsalves W, Warsame R, Kyle RA, Rajkumar V, Parikh SA, Kapoor P.

Br J Haematol. 2019 Aug 29. doi: 10.1111/bjh.16168. [Epub ahead of print]

PMID:
31468508
6.

Hot topics in interventional cardiology: Proceedings from the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Think Tank.

Naidu SS, Daniels MJ, Elmariah S, Garcia S, Klein AJ, Feldman DN, Ing FF, Kavinsky CJ, Devireddy C, Mahmud E, Grines CL, Henry TD, Duffy PL, Amin ZC, Aronow HD, Banerjee S, Brilakis ES, Herrmann HC, Hijazi ZM, Jaffer FA, Latif F, Messenger JC, Parikh SA, Poulin MF, Reilly JP, Rosenfield K, Szerlip M, Vincent RN, Cox DA; And the members of the SCAI 2019 Think Tank Consortium:, Baker D, Bhalla N, Bowen R, Camp C, Govender D, Haggstrom K, Hargus N, Hite D, Meikle J, Mylor B, Pierce V, Prince B, Roach J, Rudy J, Schludi B, Struck J, Tochterman A, Tolve M, William DM, Yowe S.

Catheter Cardiovasc Interv. 2019 Oct 1;94(4):598-606. doi: 10.1002/ccd.28449. Epub 2019 Aug 23. No abstract available.

PMID:
31441590
7.

Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics.

Tzafriri AR, Parikh SA, Edelman ER.

J Control Release. 2019 Sep 28;310:94-102. doi: 10.1016/j.jconrel.2019.08.019. Epub 2019 Aug 17.

PMID:
31430500
8.

Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015.

Bikdeli B, Wang Y, Jimenez D, Parikh SA, Monreal M, Goldhaber SZ, Krumholz HM.

JAMA. 2019 Aug 13;322(6):574-576. doi: 10.1001/jama.2019.8594. No abstract available.

PMID:
31408124
9.

Clinical characteristics and outcomes of Richter transformation: Experience of 204 patients from a single center.

Wang Y, Tschautscher MA, Rabe KG, Call TG, Leis JF, Kenderian SS, Kay NE, Muchtar E, Van Dyke DL, Koehler AB, Schwager SM, Slager SL, Parikh SA, Ding W.

Haematologica. 2019 Jun 13. pii: haematol.2019.224121. doi: 10.3324/haematol.2019.224121. [Epub ahead of print]

10.

A Woman With Multiparity Experiencing Chest Pain in Her Early 60s.

Gaba P, Parikh SA, Collins MB.

JAMA Cardiol. 2019 Jul 1;4(7):710-711. doi: 10.1001/jamacardio.2018.4511. No abstract available.

PMID:
31188394
11.

Improved Interpretability of Machine Learning Model Using Unsupervised Clustering: Predicting Time to First Treatment in Chronic Lymphocytic Leukemia.

Chen D, Goyal G, Go RS, Parikh SA, Ngufor CG.

JCO Clin Cancer Inform. 2019 May;3:1-11. doi: 10.1200/CCI.18.00137.

12.

Ethical dilemma regarding more than one biopsy reimbursement.

Parikh SA, Grant-Kels JM.

J Am Acad Dermatol. 2019 Jun;80(6):1801-1803. doi: 10.1016/j.jaad.2017.08.008. No abstract available.

PMID:
31103161
13.

Vascular Teams in Peripheral Vascular Disease.

Kolte D, Parikh SA, Piazza G, Shishehbor MH, Beckman JA, White CJ, Jaff MR, Iribarne A, Nguyen TC, Froehlich JB, Rosenfield K, Aronow HD; ACC Peripheral Vascular Disease Council.

J Am Coll Cardiol. 2019 May 21;73(19):2477-2486. doi: 10.1016/j.jacc.2019.03.463. Review.

PMID:
31097169
14.

Hemopericardium and Cardiac Tamponade as a Complication of Vena Caval Filters: Systematic Review of the Published Literature and the MAUDE Database.

Bikdeli B, Kirtane AJ, Jimenez D, Green P, Spencer FA, Kuo WT, Krumholz HM, Parikh SA.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619849111. doi: 10.1177/1076029619849111. No abstract available.

15.

Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies.

Peterson JF, Baughn LB, Ketterling RP, Pitel BA, Smoley SA, Vasmatzis G, Smadbeck JB, Greipp PT, Mangaonkar AA, Thompson CA, Parikh SA, Chen D, Viswanatha DS.

Blood Adv. 2019 Apr 23;3(8):1298-1302. doi: 10.1182/bloodadvances.2019031450. No abstract available.

16.

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

Hampel PJ, Ding W, Call TG, Rabe KG, Kenderian SS, Witzig TE, Muchtar E, Leis JF, Chanan-Khan AA, Koehler AB, Fonder AL, Schwager SM, Slager SL, Shanafelt TD, Kay NE, Parikh SA.

Leuk Lymphoma. 2019 Apr 24:1-8. doi: 10.1080/10428194.2019.1602268. [Epub ahead of print]

PMID:
31014142
17.

Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.

Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, Nowakowski GS, Thanarajasingam G, Habermann TM, Vassallo R, Sher T, Parikh SA, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group.

Haematologica. 2019 Apr 19. pii: haematol.2019.219626. doi: 10.3324/haematol.2019.219626. [Epub ahead of print]

18.

Sham-Controlled Randomized Trials of Catheter-Based Renal Denervation in Patients With Hypertension.

Sardar P, Bhatt DL, Kirtane AJ, Kennedy KF, Chatterjee S, Giri J, Soukas PA, White WB, Parikh SA, Aronow HD.

J Am Coll Cardiol. 2019 Apr 9;73(13):1633-1642. doi: 10.1016/j.jacc.2018.12.082.

PMID:
30947915
19.

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival.

Vendramini E, Bomben R, Pozzo F, Benedetti D, Bittolo T, Rossi FM, Dal Bo M, Rabe KG, Pozzato G, Zaja F, Chiarenza A, Di Raimondo F, Braggio E, Parikh SA, Kay NE, Shanafelt TD, Del Poeta G, Gattei V, Zucchetto A.

Leukemia. 2019 Aug;33(8):2111-2115. doi: 10.1038/s41375-019-0444-6. Epub 2019 Mar 14. No abstract available.

20.

Drug-Eluting Stent Implantation and Long-Term Survival Following Peripheral Artery Revascularization.

Secemsky EA, Kundi H, Weinberg I, Schermerhorn M, Beckman JA, Parikh SA, Jaff MR, Mustapha J, Rosenfield K, Yeh RW.

J Am Coll Cardiol. 2019 May 28;73(20):2636-2638. doi: 10.1016/j.jacc.2019.02.020. Epub 2019 Mar 1. No abstract available.

PMID:
30831175
21.

The Use of AngioVac Thrombectomy in IVC Filter-Associated IVC Thrombosis.

Saha A, Poterucha TJ, Parikh SA, Kirtane AJ, Sethi SS, Green P.

JACC Cardiovasc Interv. 2019 Mar 11;12(5):e41-e43. doi: 10.1016/j.jcin.2018.10.044. Epub 2019 Feb 13. No abstract available.

PMID:
30772292
22.

Transcatheter Cardiovascular Therapeutics 2018.

Mintz GS, Stone GW, Granada JF, Mehran R, Kirtane A, Dangas G, Parikh SA, Leon MB.

Eur Heart J. 2019 Feb 14;40(7):568-571. doi: 10.1093/eurheartj/ehy896. No abstract available.

PMID:
30768208
23.

Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices.

Secemsky EA, Kundi H, Weinberg I, Jaff MR, Krawisz A, Parikh SA, Beckman JA, Mustapha J, Rosenfield K, Yeh RW.

JAMA Cardiol. 2019 Apr 1;4(4):332-340. doi: 10.1001/jamacardio.2019.0325.

PMID:
30747949
24.

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy.

Sinha S, Boysen JC, Chaffee KG, Kabat BF, Slager SL, Parikh SA, Secreto CR, Call T, Shanafelt TD, Leis JF, Warner SL, Bearss DJ, Ghosh AK, Kay NE.

Oncotarget. 2018 Dec 14;9(98):37173-37184. doi: 10.18632/oncotarget.26444. eCollection 2018 Dec 14.

25.

Strength of Evidence Underlying the American Heart Association/American College of Cardiology Guidelines on Endovascular and Surgical Treatment of Peripheral Vascular Disease.

Sardar P, Giri J, Jaff MR, Parikh SA, Kundu A, White CJ, Chatterjee S, Kennedy KF, Desai NR, Hyder ON, Mukherjee D, Shishehbor MH, Abbott JD, Aronow HD.

Circ Cardiovasc Interv. 2019 Jan;12(1):e007244. doi: 10.1161/CIRCINTERVENTIONS.118.007244.

PMID:
30608884
26.

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

Fang H, Reichard KK, Rabe KG, Hanson CA, Call TG, Ding W, Kenderian SS, Muchtar E, Schwager SM, Leis JF, Chanan-Khan AA, Slager SL, Braggio E, Smoley SA, Kay NE, Shanafelt TD, Van Dyke DL, Parikh SA.

Am J Hematol. 2019 Mar;94(3):338-345. doi: 10.1002/ajh.25385. Epub 2019 Jan 8.

PMID:
30575108
27.

ACC/AHA/SCAI/SIR/SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Heart Association, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, and Society for Vascular Medicine.

Bailey SR, Beckman JA, Dao TD, Misra S, Sobieszczyk PS, White CJ, Wann LS, Bailey SR, Dao T, Aronow HD, Fazel R, Gornik HL, Gray BH, Halperin JL, Hirsch AT, Jaff MR, Krishnamurthy V, Parikh SA, Reed AB, Shamoun F, Shugart RE, Yucel EK.

J Am Coll Cardiol. 2019 Jan 22;73(2):214-237. doi: 10.1016/j.jacc.2018.10.002. Epub 2018 Dec 17. No abstract available.

PMID:
30573393
28.

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.

Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JC.

N Engl J Med. 2018 Dec 27;379(26):2517-2528. doi: 10.1056/NEJMoa1812836. Epub 2018 Dec 1.

29.

SCAI 2018 Think Tank Proceedings: "What skillsets are required of vascular interventional cardiologists in evaluating and managing critical limb ischemia (CLI)? What role should SCAI play in supporting interventional cardiologists in their CLI practices, individually and collectively?"

Hawkins BM, Aronow HD, Parikh SA, Rosenfield K, Naidu SS; And the members of the SCAI 2018 Think Tank Consortium: Ellie Boutin, Fennel B, Fontenot K, Nicolosi M, Tieche C.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):511-513. doi: 10.1002/ccd.27900. Epub 2018 Nov 29.

PMID:
30489007
30.

Correction to: Decision Tree Based Classification of Abdominal Aortic Aneurysms Using Geometry Quantification Measures.

Parikh SA, Gomez R, Thirugnanasambandam M, Chauhan SS, De Oliveira V, Muluk SC, Eskandari MK, Finol EA.

Ann Biomed Eng. 2019 Jan;47(1):332. doi: 10.1007/s10439-018-02131-x.

PMID:
30377896
31.

Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry.

Bikdeli B, Lobo JL, Jiménez D, Green P, Fernández-Capitán C, Bura-Riviere A, Otero R, DiTullio MR, Galindo S, Ellis M, Parikh SA, Monreal M; RIETE Investigators.

J Am Heart Assoc. 2018 Sep 4;7(17):e009042. doi: 10.1161/JAHA.118.009042.

32.

Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.

Manso BA, Zhang H, Mikkelson MG, Gwin KA, Secreto CR, Ding W, Parikh SA, Kay NE, Medina KL.

Leukemia. 2019 Mar;33(3):638-652. doi: 10.1038/s41375-018-0280-0. Epub 2018 Oct 5.

33.

Have We Found the Right COMBO to Balance Vascular Injury and Healing?

Parikh SA.

JACC Cardiovasc Interv. 2018 Oct 8;11(19):1979-1981. doi: 10.1016/j.jcin.2018.05.037. No abstract available.

PMID:
30286856
34.

Chronic lymphocytic leukemia treatment algorithm 2018.

Parikh SA.

Blood Cancer J. 2018 Oct 3;8(10):93. doi: 10.1038/s41408-018-0131-2. Review.

35.

Cryptococcus neoformans infections in patients with lymphoproliferative neoplasms.

Dioverti MV, Parikh SA, Osmon DR, Habermann TM, Tande AJ.

Leuk Lymphoma. 2019 Apr;60(4):920-926. doi: 10.1080/10428194.2018.1508666. Epub 2018 Sep 6.

PMID:
30188226
36.

Decision Tree Based Classification of Abdominal Aortic Aneurysms Using Geometry Quantification Measures.

Parikh SA, Gomez R, Thirugnanasambandam M, Chauhan SS, De Oliveira V, Muluk SC, Eskandari MK, Finol EA.

Ann Biomed Eng. 2018 Dec;46(12):2135-2147. doi: 10.1007/s10439-018-02116-w. Epub 2018 Aug 21. Erratum in: Ann Biomed Eng. 2018 Sep 18;:.

PMID:
30132212
37.

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.

Hampel PJ, Larson MC, Kabat B, Call TG, Ding W, Kenderian SS, Bowen D, Boysen J, Schwager SM, Leis JF, Chanan-Khan AA, Muchtar E, Hanson CA, Slager SL, Kay NE, Chaffee KG, Shanafelt TD, Parikh SA.

Br J Haematol. 2018 Nov;183(3):421-427. doi: 10.1111/bjh.15545. Epub 2018 Aug 16.

PMID:
30117139
38.

A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses.

McCarter SJ, Vijayvargiya P, Sidana S, Nault AM, Lane CE, Lehman JS, Wilson JW, Parikh SA, Nowakowski GS, Al-Kali A.

Leuk Lymphoma. 2019 Feb;60(2):559-561. doi: 10.1080/10428194.2018.1494271. Epub 2018 Aug 2. No abstract available.

PMID:
30070153
39.

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases.

Morabito F, Shanafelt TD, Gentile M, Reda G, Mauro FR, Rossi D, Di Renzo N, Molica S, Angrilli F, Chiarenza A, Cutrona G, Chaffee KG, Parikh SA, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Cortelezzi A, Gaidano G, Di Raimondo F, Fais F, Foà R, Neri A, Ferrarini M.

Am J Hematol. 2018 Sep;93(9):E216-E219. doi: 10.1002/ajh.25206. Epub 2018 Jul 30. No abstract available.

40.

PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.

He R, Ding W, Viswanatha DS, Chen D, Shi M, Van Dyke D, Tian S, Dao LN, Parikh SA, Shanafelt TD, Call TG, Ansell SM, Leis JF, Mai M, Hanson CA, Rech KL.

Am J Surg Pathol. 2018 Jul;42(7):843-854. doi: 10.1097/PAS.0000000000001077.

PMID:
29762141
41.

SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions.

Feldman DN, Armstrong EJ, Aronow HD, Gigliotti OS, Jaff MR, Klein AJ, Parikh SA, Prasad A, Rosenfield K, Shishehbor MH, Swaminathan RV, White CJ.

Catheter Cardiovasc Interv. 2018 Jul;92(1):124-140. doi: 10.1002/ccd.27635. Epub 2018 Apr 24. Review. No abstract available.

PMID:
29691970
42.

Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab.

Gentile M, Shanafelt TD, Reda G, Mauro FR, Zirlik K, Ciolli S, Laurenti L, Del Principe MI, Rossi D, Di Renzo N, Molica S, Angrilli F, Coscia M, Chiarenza A, Giordano A, Cutrona G, Chaffee KG, Parikh SA, Uccello G, Innocenti I, Tripepi G, D'Arrigo G, Vigna E, Recchia AG, Herishanu Y, Shvidel L, Tadmor T, Cortelezzi A, Del Poeta G, Gaidano G, Di Raimondo F, Neri A, Ferrarini M, Foà R, Polliack A, Morabito F.

Leukemia. 2018 Aug;32(8):1869-1873. doi: 10.1038/s41375-018-0100-6. Epub 2018 Mar 20. No abstract available.

PMID:
29588545
43.

Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia.

Kay NE, LaPlant BR, Pettinger AM, Call TG, Leis JF, Ding W, Parikh SA, Conte MJ, Bowen DA, Shanafelt TD.

Expert Rev Hematol. 2018 Apr;11(4):337-349. doi: 10.1080/17474086.2018.1442716. Epub 2018 Feb 26.

PMID:
29460654
44.

Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.

Parikh SA, Chaffee KG, Larson MC, Hampel PJ, Call TG, Ding W, Kenderian SS, Leis JF, Chanan-Khan AA, Conte MJ, Bowen D, Schwager SM, Slager SL, Hanson CA, Kay NE, Shanafelt TD.

Haematologica. 2018 Jun;103(6):e237-e240. doi: 10.3324/haematol.2017.183194. Epub 2018 Feb 1. No abstract available.

45.

Leave No Stent Behind: Are Drug-Coated Balloons Enough for Femoropopliteal Disease?

Sethi SS, Parikh SA.

Circ Cardiovasc Interv. 2018 Jan;11(1):e006285. doi: 10.1161/CIRCINTERVENTIONS.117.006285. No abstract available.

PMID:
29326156
46.

Clinical pearl: a simple and effective technique for improving surgical closures for the early-learning resident.

Parikh SA, Sloan B.

Cutis. 2017 Nov;100(5):338-339. No abstract available.

PMID:
29232428
47.

Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy.

Ayed AO, Parikh SA.

Leuk Lymphoma. 2018 Oct;59(10):2287-2296. doi: 10.1080/10428194.2017.1397665. Epub 2017 Nov 8. Review.

PMID:
29115892
48.

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

Gentile M, Shanafelt TD, Mauro FR, Laurenti L, Rossi D, Molica S, Vincelli I, Cutrona G, Uccello G, Pepe S, Vigna E, Tripepi G, Chaffee KG, Parikh SA, Bossio S, Recchia AG, Innocenti I, Pasquale R, Neri A, Ferrarini M, Gaidano G, Foà R, Morabito F.

Am J Hematol. 2018 Feb;93(2):E35-E37. doi: 10.1002/ajh.24960. Epub 2017 Nov 23. No abstract available.

49.

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

Hampel PJ, Chaffee KG, King RL, Simonetto D, Larson MC, Achenbach S, Call TG, Ding W, Kenderian SS, Leis JF, Chanan-Khan AA, Bowen DA, Conte MJ, Schwager SM, Hanson CA, Slager SL, Kay NE, Shanafelt TD, Parikh SA.

Am J Hematol. 2017 Dec;92(12):1362-1369. doi: 10.1002/ajh.24915. Epub 2017 Oct 19.

50.

A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults.

Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan MB, La Rosée P, Kantarjian HM.

Cancer. 2017 Sep 1;123(17):3229-3240. doi: 10.1002/cncr.30826. Epub 2017 Jun 16. Review.

Supplemental Content

Loading ...
Support Center